Tatva Chintan Pharma Chem Limited (TATVA.NS)
INR 703.6
(-0.13%)
INR 703.6
(-0.13%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 3.9 Billion | 4.23 Billion | 4.31 Billion | 2.96 Billion | 2.57 Billion | 2.02 Billion |
| Cost of Revenue | 2.54 Billion | 2.26 Billion | 2.07 Billion | 1.55 Billion | 1.38 Billion | 1.16 Billion |
| Gross Profit | 1.35 Billion | 1.97 Billion | 2.23 Billion | 1.41 Billion | 1.19 Billion | 861.48 Million |
| Operating Expenses | 963.65 Million | 1.46 Billion | 1.22 Billion | 807.89 Million | 656.24 Million | 541.05 Million |
| Selling, General and Administrative Expenses | 284.03 Million | 404.76 Million | 382.1 Million | 214.81 Million | 192.97 Million | 198.74 Million |
| Research and Development Expenses | 79.42 Million | 60.39 Million | 37.07 Million | 2.79 Million | 10.14 Million | 1.99 Million |
| Other Expenses | 75.09 Million | 57.44 Million | 1.33 Million | 4.5 Million | 453.13 Million | 390 Thousand |
| Cost and Expenses | 3.5 Billion | 3.72 Billion | 3.3 Billion | 2.36 Billion | 2.04 Billion | 1.7 Billion |
| Operating Income | 422.17 Million | 584.69 Million | 1 Billion | 601.81 Million | 532.5 Million | 317 Million |
| Interest Expense | 61.51 Million | 84.04 Million | 42.32 Million | 39.85 Million | 37.52 Million | 32.98 Million |
| Income Tax Expense | 132.13 Million | -7.08 Million | 82.47 Million | 84.34 Million | 98.08 Million | 68.5 Million |
| Earnings before Tax | 435.68 Million | 447.79 Million | 1.04 Billion | 606.96 Million | 475.97 Million | 273.93 Million |
| Net Income | 303.54 Million | 454.87 Million | 958.74 Million | 522.62 Million | 377.89 Million | 205.43 Million |
| Earnings Per Share Basic | 13.26 | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 |
| Earnings Per Share Diluted | 13.26 | 20.52 | 44.59 | 26.02 | 18.81 | 10.23 |
| Weighted Average Shares Outstanding | 22.89 Million | 22.16 Million | 21.49 Million | 20.08 Million | 20.08 Million | 20.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.88 Million | 22.16 Million | 21.49 Million | 20.08 Million | 20.08 Million | 20.08 Million |
| Gross Margin | 0.35 | 0.47 | 0.52 | 0.48 | 0.46 | 0.43 |
| EBIT Margin | 0.19 | 0.16 | 0.27 | 0.24 | 0.22 | 0.17 |
| Profit Margin | 0.08 | 0.11 | 0.22 | 0.18 | 0.15 | 0.10 |
| EBITDA | 756.71 Million | 626.96 Million | 1.16 Billion | 717.71 Million | 566.19 Million | 353.39 Million |
| Earnings Before Tax Margin | 0.11 | 0.14 | 0.23 | 0.20 | 0.21 | 0.16 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 834.9 Million | 1.05 Billion | 3.93 Billion | 982.66 Million | 842.06 Million | 966.69 Million |
| Cost of Revenue | 427.21 Million | 763.59 Million | 2.54 Billion | 620.77 Million | 373.42 Million | 373.14 Million |
| Gross Profit | 407.69 Million | 291.05 Million | 1.38 Billion | 361.89 Million | 468.64 Million | 593.55 Million |
| Operating Expenses | 419.95 Million | 231.55 Million | 963.65 Million | 268.13 Million | 424.53 Million | 458.84 Million |
| Selling, General and Administrative Expenses | 222.43 Million | 231.55 Million | - | 268.13 Million | 211.04 Million | 140.69 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 419.95 Million | 11.73 Million | 75.09 Million | 45.28 Million | 12.1 Million | 7.56 Million |
| Cost and Expenses | 847.16 Million | 995.14 Million | 3.5 Billion | 888.9 Million | 797.95 Million | 831.98 Million |
| Operating Income | -12.26 Million | 59.5 Million | 425.91 Million | 93.76 Million | 56.21 Million | 134.71 Million |
| Interest Expense | 1.72 Million | 3.14 Million | 65.32 Million | 2.15 Million | 3.77 Million | 30.14 Million |
| Income Tax Expense | -3.57 Million | 16 Million | 132.13 Million | 40.76 Million | 17.89 Million | 34.32 Million |
| Earnings before Tax | -10.21 Million | 68.09 Million | 435.68 Million | 136.9 Million | 52.44 Million | 112.13 Million |
| Net Income | -6.64 Million | 52.09 Million | 303.54 Million | 96.14 Million | 34.55 Million | 77.81 Million |
| Earnings Per Share Basic | -0.29 | 2.23 | - | 4.11 | 1.48 | 3.43 |
| Earnings Per Share Diluted | -0.29 | 2.23 | - | 4.11 | 1.48 | 3.43 |
| Weighted Average Shares Outstanding | 22.89 Million | 23.39 Million | 22.89 Million | 23.39 Million | 23.39 Million | 22.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.89 Million | 23.39 Million | 22.89 Million | 23.39 Million | 23.39 Million | 22.68 Million |
| Gross Margin | 0.49 | 0.28 | 0.35 | 0.37 | 0.56 | 0.61 |
| EBIT Margin | 0.07 | 0.12 | - | 0.16 | 0.14 | 0.22 |
| Profit Margin | -0.01 | 0.05 | 0.08 | 0.10 | 0.04 | 0.08 |
| EBITDA | 59.64 Million | 126.15 Million | - | 156.09 Million | 122.04 Million | 210.04 Million |
| Earnings Before Tax Margin | -0.01 | 0.06 | 0.11 | 0.10 | 0.07 | 0.14 |
600127
000893
001229
IMCC
OBIIF
ARRY